Approximately half of all IMTs exhibit anaplastic lymphoma kinase (ALK) gene rearrangements [4], which are considered to be an IMT marker, as are expression of vimentin, muscle-specific actin, and calponin [5-7]. The gene discussed is ALK; the disease is inflammatory myofibroblastic tumor.